Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Wang-Chun Kwok"'
Autor:
Wang-Chun Kwok, David Christopher Lung, Terence Chi-Chun Tam, Desmond Yat-Hin Yap, Ting-Fung Ma, Chung-Ki Tsui, Ru Zhang, David Chi-Leung Lam, Mary Sau-Man Ip, James Chung-Man Ho
Publikováno v:
Vaccines, Vol 12, Iss 7, p 704 (2024)
Influenza is an important respiratory viral pathogen in adults, with secondary bacterial pneumonia being a common complication. While pneumococcal vaccines can prevent pneumococcal pneumonia and invasive pneumococcal disease, whether they can also pr
Externí odkaz:
https://doaj.org/article/b2c7b777e8f9495fabc44d5db8d3055e
Autor:
Wang-Chun Kwok, Ka-Chun Wong, Ting-Fung Ma, Ka-Wai Ho, Louis Wai-Tong Fan, King-Pui Florence Chan, Samuel Shung-Kay Chan, Terence Chi-Chun Tam, Pak-Leung Ho
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Coronavirus Disease 2019 (COVID-19) led to pandemic that affected almost all countries in the world. Many countries have implemented border restriction as a public health measure to limit local outbreak. However, there is inadequa
Externí odkaz:
https://doaj.org/article/86045dc3bc154cff89a1dc9f801bffe1
Autor:
Wang-Chun Kwok, Chun-Ka Wong, Ting-Fung Ma, Ka-Wai Ho, Louis Wai-Tong Fan, King-Pui Florence Chan, Samuel Shung-Kay Chan, Terence Chi-Chun Tam, Pak-Leung Ho
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/f1d8a9c5563244c292ef054722056754
Autor:
Wang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, Mary Sau Man Ip, David Chi Leung Lam
Publikováno v:
Thoracic Cancer, Vol 13, Iss 14, Pp 2057-2063 (2022)
Abstract Background Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are recommended as first‐line treatment in non‐small cell lung cancer (NSCLC) patients with sensitizing EGFR mutations. The sequential use of differen
Externí odkaz:
https://doaj.org/article/c9b861ec2a164dd48fbda80b0616ff37
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Amiodarone is one of the most commonly used anti-arrhythmic agents. Amiodarone pulmonary toxicity is a potentially fatal adverse effect associated with amiodarone use. Previous studies on the epidemiology and risk factors for amio
Externí odkaz:
https://doaj.org/article/629f0f6032144d85bed137fe291174b3
Publikováno v:
Journal of Asthma and Allergy. 16:315-321
Wang Chun Kwok,1 Terence Chi Chun Tam,1 Chor Wing Sing,2 Esther Wai Yin Chan,2 Ching-Lung Cheung2 1Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, Peopleâs Republic of
Autor:
Wang Chun Kwok, Sze Him Isaac Leung, Terence Chi Chun Tam, James Chung Man Ho, David Chi-Leung Lam, Mary Sau Man Ip, Pak Leung Ho
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 18:47-56
Wang Chun Kwok,1,* Sze Him Isaac Leung,2,* Terence Chi Chun Tam,1 James Chung Man Ho,1 David Chi-Leung Lam,1 Mary Sau Man Ip,1 Pak Leung Ho3 1Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administ
Publikováno v:
Pharmacoepidemiology and Drug Safety.
Autor:
Wang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, Mary Sau Man Ip, David Chi Leung Lam
Publikováno v:
Thoracic Cancer. 13:2057-2063
Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are recommended as first-line treatment in non-small cell lung cancer (NSCLC) patients with sensitizing EGFR mutations. The sequential use of different EGFR-TKIs has been reporte
Autor:
Wang Chun, Kwok, James Chung Man, Ho, Terence Chi Chun, Tam, Mary Sau Man, Ip, David Chi Leung, Lam
Publikováno v:
J Thorac Dis
BACKGROUND: Afatinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with significant serum protein binding. Total protein level was found to be associated with plasma afatinib level. The trough serum concentration was shown t